The Promise and Reality of NGTs

Watch and Listen to 2022’s Summer Special episode

Our Transformation Talks Summer Special is here!

Next Generation Therapies (NGTs) currently in development will deliver treatments that address the underlying cause of diseases, disrupt the biopharmaceutical environment, and offer a life-long solution to patients. They create unprecedented opportunities for patients and will be measurable in lives saved, disabilities reduced, and overall quality of life improvements. However, along with these benefits come unprecedented challenges for insurance coverage, reimbursement, and payment.

Tune in to learn about risks and challenges in developing NGTs, bringing them to the market, and how NGTs can change patients’ lives once their value is understood and correctly attributed by the decision makers / payers.

This special episode is not only be available in audio format but also in video and features a stellar group of guests:

  • Andrea Mantovani – Vice President, Global Market Access and Pricing, Alira Health
  • Oswald Bentinck – Vice President – Head of Market Access EMEA, Novartis Gene Therapies
  • Pietro Sternini – Executive Director, Gene Therapy Market Access & Marketing Lead, EMEA, Astellas Gene Therapies
Watch the episode “The Promise and Reality of NGTs”:

Listen to the episode:

The episode “The Promise and Reality of Next Generation Therapies” is also available on the following platforms:

Google Podcasts      Spotify

Multimedia
Category:
Published on:
July 20, 2022
Meet our speakers:
Andrea Mantovani

Andrea Mantovani

Vice President, Global Market Access and Pricing, Alira Health
Oswald Bentinck headshot

Oswald Bentinck

Vice President - Head of Market Access EMEA, Novartis Gene Therapies
Pietro Sternini headshot

Pietro Sternini

Executive Director, Gene Therapy Market Access & Marketing Lead, EMEA, Astellas Gene Therapies
Meet our host:
Kenny Carberry

Kenny Carberry

Director, Clinical Development, Alira Health

Related news

News November 15, 2022
Alira Health Partners with Policy Matters to Foster Market Access in the UK
Alira Health, a global advisory and clinical research firm whose mission is to humanize healthcare and life sciences, announces its partnership with leading UK market access specialist(...)
Digital Health Healthcare Consulting Market Access
News November 10, 2022
Alira Health and GDMH together to boost Life Sciences innovation
The companies join forces for collaborative research and co-development of projects in the fields of Digital Health, Real-World Evidence and Market Access.
Clinical Trials Digital Health DTx Market Access Real-World Evidence RWE
Events October 7, 2022
Debate Sobre los IPT en Oncología
We are pleased to announce our next event, “Debate Sobre los IPT en Oncología,” focusing on price and reimbursement (P&R) of vital oncology and oncohematology therapies.
Market Access Product Development Regulatory
Publications October 5, 2022
Relative Weight of the Variables Evaluated Through the Therapeutic Positioning Reports in the Pricing and Reimbursement of Oncological and Oncohematology Medicines in Spain
Discover how companies’ target prices are impacted by the different variables leveraged during the P&R process for oncology and oncohematology’s first indication.
Market Access Oncology Spain
News October 4, 2022
Alira Health enhances its market access services through a strategic partnership with Centivis
Alira Health, a global healthcare advisory and technology company, announced a strategic partnership with Centivis AG, a boutique market access consulting agency, specializing in digital(...)
Digital Health Market Access MedTech Pharma Regulatory
News September 27, 2022
AseBio and Alira Health Partner to Foster Market Access for Biotech Startups
Alira Health and AseBio, the Spanish Bioindustry Association, are joining forces to support Spanish biotech companies looking to enter new markets.
Biotech Market Access Startups
News September 6, 2022
Alira Health Expands North American Capabilities with the Acquisition of Artisan Healthcare Consulting
The acquisition of Artisan strengthens and extends Alira Health’s Market Access and Management Consulting advisory practices in North America and globally.
Biotech Market Access Pharma Therapeutics
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.